Funding {4}
TB, Infection
INFECTION
Open Access funding enabled and organized by Projekt DEAL. The study is funded by LegoChem Biosciences, Inc, and conducted under the umbrella of PanACEA, the PanAfrican Consortium for the Evaluation of anti-TB Antibiotics, which receives funding through the European and Developing Countries Clinical Trials Partnership (EDCTP, grant number TRIA2015-1102 PanACEA), the German Ministry for Education and Research (BMBF, grant number 01KA1701), and the German Center for Infection Research (DZIF). PanACEA is a not-for-profit consortium with the goal of shortening the treatment regimen of drug-sensitive TB.